OBJECTIVE: Emerging research suggests that yoga may be beneficial for reducing symptoms and improving quality of life among breast cancer patients. However, very little is known about the characteristics of breast cancer patients who use yoga; thus, this study seeks to identify the sociodemographic and clinical characteristics of yoga users among this population. DESIGN: A cross-sectional survey study was conducted. SETTING: The study was conducted at an outpatient breast oncology clinic at a large university hospital. PARTICIPANTS: Three hundred postmenopausal breast cancer patients currently receiving aromatase inhibitors were included in this study. MAIN OUTCOME MEASUREMENT: Self-reported use of yoga following the cancer diagnosis was collected along with sociodemographic and clinical data. Multivariate logistic regression was used to identify independent predictors of yoga use among breast cancer patients. RESULTS: Of 300 participants, 53 (17.7%) reported having used yoga following cancer diagnosis. White patients were significantly more likely to use yoga than nonwhite patients (P = .02). Higher education level, lower BMI (body mass index), part-time employment status, previous chemotherapy, and radiation therapy were all associated with greater yoga use (all P < .05). Controlling for other factors, greater yoga use was independently associated with higher education level (adjusted odds ratio [AOR] 2.72, 95% confidence interval [CI], 1.15-6.46), and lower BMI (AOR 0.25, 95% CI, 0.09-0.66). CONCLUSION: Yoga use following breast cancer diagnosis was substantially higher for white patients and those with lower BMI and higher education levels. Considering its potential benefits for symptom management in cancer, more research is needed to understand the attitudes and barriers to yoga use among individuals with nonwhite race, lower education, and higher BMI level. Such investigation will help design yoga programs that are aligned to the needs of these populations.
OBJECTIVE: Emerging research suggests that yoga may be beneficial for reducing symptoms and improving quality of life among breast cancerpatients. However, very little is known about the characteristics of breast cancerpatients who use yoga; thus, this study seeks to identify the sociodemographic and clinical characteristics of yoga users among this population. DESIGN: A cross-sectional survey study was conducted. SETTING: The study was conducted at an outpatient breast oncology clinic at a large university hospital. PARTICIPANTS: Three hundred postmenopausal breast cancerpatients currently receiving aromatase inhibitors were included in this study. MAIN OUTCOME MEASUREMENT: Self-reported use of yoga following the cancer diagnosis was collected along with sociodemographic and clinical data. Multivariate logistic regression was used to identify independent predictors of yoga use among breast cancerpatients. RESULTS: Of 300 participants, 53 (17.7%) reported having used yoga following cancer diagnosis. White patients were significantly more likely to use yoga than nonwhite patients (P = .02). Higher education level, lower BMI (body mass index), part-time employment status, previous chemotherapy, and radiation therapy were all associated with greater yoga use (all P < .05). Controlling for other factors, greater yoga use was independently associated with higher education level (adjusted odds ratio [AOR] 2.72, 95% confidence interval [CI], 1.15-6.46), and lower BMI (AOR 0.25, 95% CI, 0.09-0.66). CONCLUSION: Yoga use following breast cancer diagnosis was substantially higher for white patients and those with lower BMI and higher education levels. Considering its potential benefits for symptom management in cancer, more research is needed to understand the attitudes and barriers to yoga use among individuals with nonwhite race, lower education, and higher BMI level. Such investigation will help design yoga programs that are aligned to the needs of these populations.
Authors: R Moschèn; G Kemmler; H Schweigkofler; B Holzner; M Dünser; R Richter; W W Fleischhacker; B Sperner-Unterweger Journal: Support Care Cancer Date: 2001-06 Impact factor: 3.603
Authors: Cecile A Lengacher; Mary P Bennett; Kevin E Kip; Rosemary Keller; Melisa S LaVance; Lynette S Smith; Charles E Cox Journal: Oncol Nurs Forum Date: 2002 Nov-Dec Impact factor: 2.172
Authors: Birendranath Banerjee; H S Vadiraj; Amritanshu Ram; Raghavendra Rao; Manikandan Jayapal; Kodaganur S Gopinath; B S Ramesh; Nalini Rao; Ajay Kumar; Nagarathna Raghuram; Sridevi Hegde; H R Nagendra; M Prakash Hande Journal: Integr Cancer Ther Date: 2007-09 Impact factor: 3.279
Authors: Alyson B Moadel; Chirag Shah; Judith Wylie-Rosett; Melanie S Harris; Sapana R Patel; Charles B Hall; Joseph A Sparano Journal: J Clin Oncol Date: 2007-09-04 Impact factor: 44.544
Authors: Ernest Rosenbaum; Holly Gautier; Pat Fobair; Eric Neri; Bernadette Festa; Margaret Hawn; Alexandra Andrews; Nama Hirshberger; Sabrina Selim; David Spiegel Journal: Support Care Cancer Date: 2004-02-26 Impact factor: 3.603
Authors: R M Raghavendra; R Nagarathna; H R Nagendra; K S Gopinath; B S Srinath; B D Ravi; S Patil; B S Ramesh; R Nalini Journal: Eur J Cancer Care (Engl) Date: 2007-11 Impact factor: 2.520
Authors: James W Carson; Kimberly M Carson; Laura S Porter; Francis J Keefe; Heather Shaw; Julie M Miller Journal: J Pain Symptom Manage Date: 2007-03 Impact factor: 3.612
Authors: M Kalder; T Müller; D Fischer; A Müller; W Bader; M W Beckmann; C Brucker; C C Hack; V Hanf; A Hasenburg; A Hein; S Jud; M Kiechle; E Klein; D Paepke; A Rotmann; F Schütz; G Dobos; P Voiß; S Kümmel Journal: Geburtshilfe Frauenheilkd Date: 2016-02 Impact factor: 2.915
Authors: Daniela L Stan; Nerissa M Collins; Molly M Olsen; Ivana Croghan; Sandhya Pruthi Journal: Evid Based Complement Alternat Med Date: 2012-09-11 Impact factor: 2.629
Authors: Krupali Desai; Ting Bao; Qing S Li; Nirupa J Raghunathan; Kelly Trevino; Angela Green; Han Xiao; Jun J Mao Journal: Support Care Cancer Date: 2021-03-04 Impact factor: 3.359
Authors: Melissa Adair; Barbara Murphy; Sujatha Yarlagadda; Jie Deng; Mary S Dietrich; Sheila H Ridner Journal: Integr Cancer Ther Date: 2018-01-22 Impact factor: 3.279